ClinicalTrials.gov
public full text
Public Domain
Personalized Medicine for Diabetes Prediction and Prevention of Complications
The metabolic syndrome is a collection of related risk factors that predispose to the development of type 2 diabetes Mellitus and cardiovascular disease. The investigators will examine the hypothesis that the metabolic and genomic characteristics of patients with metabolic syndrome and/or diabetes that are at risk for developing complications differ from each other and can be detected using specific biomarkers in blood or in the exhaled breath. Early detection of these individuals will enable personalized treatment to prevent and treat diabetes and its complications
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Nutrigenetic Intervention on Blood Lipid Markers and Body Composition of Adults With Overweight and Obesity#811843
- Diagnosis and Management of the Metabolic Syndrome#6886
- Mechanisms of Hypoglycemia in Patients Without Diabetes#1048097
- Genetic analysis of circulating metabolic traits in 619,372 individuals.#396282
- Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)#314446
Record · ID 1094575
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive